Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo

References

• BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• GolanT, HammelP, ReniM, et al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med. 2019;381(4):317–327. doi:10.1056/NEJMoa190338731157963
   PubMed Web of Science ®Google Scholar
• IlicM, IlicI. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–9705. doi:10.3748/wjg.v22.i44.969427956793
   PubMed Web of Science ®Google Scholar
• HongJC, CzitoBG, WillettCG, PaltaM. A current perspective on stereotactic body radiation therapy for pancreatic cancer. Onco Targets Ther. 2016;9:6733–6739. doi:10.2147/OTT.S9982627826200
   PubMed Web of Science ®Google Scholar
• GongR, JiangY. Non-coding RNAs in pancreatic ductal adenocarcinoma. Front Oncol. 2020;10:309. doi:10.3389/fonc.2020.0030932257946
   PubMed Web of Science ®Google Scholar
• JiQ, HaoX, ZhangM, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 2009;4(8):e6816. doi:10.1371/journal.pone.000681619714243
   PubMed Web of Science ®Google Scholar
• TangY, TangY, ChengY-S. miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial–mesenchymal transition and the notch signaling pathway. Sci Rep. 2017;7(1):38232. doi:10.1038/srep3823228145431
   PubMed Web of Science ®Google Scholar
• AlemarB, IzettiP, GregorioC, et al. miRNA-21 and miRNA-34a are potential minimally invasive biomarkers for the diagnosis of pancreatic ductal adenocarcinoma. Pancreas. 2016;45(1):84–92. doi:10.1097/MPA.000000000000038326262588
   PubMed Web of Science ®Google Scholar
• BartelDP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• AmbrosV. The functions of animal microRNAs. Nature. 2004;431(7006):350–355. doi:10.1038/nature0287115372042
   PubMed Web of Science ®Google Scholar
• JeppesenDK, FenixAM, FranklinJL, et al. Reassessment of exosome composition. Cell. 2019;177(2):428–445 e418. doi:10.1016/j.cell.2019.02.02930951670
   PubMed Web of Science ®Google Scholar
• Van der MeelR, FensMH, VaderP, van SolingeWW, Eniola-AdefesoO, SchiffelersRM. Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Controlled Release. 2014;195:72–85. doi:10.1016/j.jconrel.2014.07.049
   PubMed Web of Science ®Google Scholar
• ValadiH, EkstromK, BossiosA, SjostrandM, LeeJJ, LotvallJO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi:10.1038/ncb159617486113
   PubMed Web of Science ®Google Scholar
• JiangXC, GaoJQ. Exosomes as novel bio-carriers for gene and drug delivery. Int J Pharm. 2017;521(1):167–175. doi:10.1016/j.ijpharm.2017.02.03828216464
   PubMed Web of Science ®Google Scholar
• Alvarez-ErvitiL, SeowY, YinH, BettsC, LakhalS, WoodMJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345. doi:10.1038/nbt.180721423189
   PubMed Web of Science ®Google Scholar
• ShimboK, MiyakiS, IshitobiH, et al. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun. 2014;445(2):381–387. doi:10.1016/j.bbrc.2014.02.00724525123
   PubMed Web of Science ®Google Scholar
• LiuT, ZhangX, DuL, et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer. 2019;18(1):43. doi:10.1186/s12943-019-0981-730890168
   PubMed Web of Science ®Google Scholar
• OhnoS, TakanashiM, SudoK, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21(1):185–191. doi:10.1038/mt.2012.18023032975
   PubMed Web of Science ®Google Scholar
• TheryC, AmigorenaS, RaposoG, ClaytonA. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:Unit 3 22.
   PubMedGoogle Scholar
• SokolovaV, LudwigAK, HornungS, et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011;87(1):146–150. doi:10.1016/j.colsurfb.2011.05.01321640565
   PubMed Web of Science ®Google Scholar
• JungMK, MunJY. Sample preparation and imaging of exosomes by transmission electron microscopy. J Vis Exp. 2018;131:e56482.
   Google Scholar
• WitwerKW, BuzasEI, BemisLT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2(1):20360. doi:10.3402/jev.v2i0.20360
   PubMedGoogle Scholar
• HermekingH. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010;17(2):193–199. doi:10.1038/cdd.2009.5619461653
   PubMed Web of Science ®Google Scholar
• RytblatI, WuN, XuHL, GedankenA, LinXK. In vitro studies of polyethyleneimine coated miRNA microspheres as anticancer agents. Nano Res. 2016;9(6):1609–1617. doi:10.1007/s12274-016-1055-4
   Web of Science ®Google Scholar
• XiongMP, ForrestML, TonG, ZhaoA, DaviesNM, KwonGS. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery. Biomaterials. 2007;28(32):4889–4900. doi:10.1016/j.biomaterials.2007.07.04317692910
   PubMed Web of Science ®Google Scholar
• YangJ, ZhangX, ChenX, WangL, YangG. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids. 2017;7:278–287. doi:10.1016/j.omtn.2017.04.01028624203
   PubMedGoogle Scholar
• JamiesonNB, MorranDC, MortonJP, et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Drugs. 2012;18(2):534–545. doi:10.1158/1078-0432.CCR-11-0679
   Google Scholar
• ChenF, HuSJ. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J Biochem Mol Toxicol. 2012;26(2):79–86. doi:10.1002/jbt.2041222162084
   PubMed Web of Science ®Google Scholar
• RokavecM, LiH, JiangL, HermekingH. The p53/miR-34 axis in development and disease. J Mol Cell Biol. 2014;6(3):214–230. doi:10.1093/jmcb/mju00324815299
   PubMed Web of Science ®Google Scholar
• LeeEJ, GusevY, JiangJ, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120(5):1046–1054. doi:10.1002/ijc.2239417149698
   PubMed Web of Science ®Google Scholar